Company Voyageur Pharmaceuticals Ltd.

VM

CA92918C1014

Pharmaceuticals

Business Summary

Managers

Members of the board

Share class

Shareholders

Company contact information

Sector

Annual profits - Rate of surprise

Sector Other Pharmaceuticals

Market Closed - Toronto S.E. Other stock markets 11:22:42 2024-05-10 am EDT			5-day change	1st Jan Change
0.055 ^CAD	0.00%		+10.00%	-26.67%

Apr. 26	Voyageur Pharmaceuticals Ltd. Reports Earnings Results for the First Quarter Ended February 29, 2024	CI
Mar. 26	Voyageur Pharmaceuticals Ltd. Reports Earnings Results for the Full Year Ended November 30, 2023	CI

Voyageur Pharmaceuticals Ltd. is a Canadian company, which develops barium, iodine and carbon active pharmaceutical ingredients. The Company is focused on producing its own barium, iodine and fullerene minerals. The Company, through its subsidiaries, Voyageur Industrial Minerals Ltd. and Voyageur Minerals Inc., is engaged in acquiring, exploring and developing raw materials for pharmaceutical products, primarily in the province of British Columbia, Canada and the state of Utah, United States. Its properties include Jubilee Mountain, Falcon and Paradox Basin. It owns a 100% interest in two barium sulphate (barite) projects, including the Frances Creek and Pedley Mountain property. It holds interests in a high-grade iodine, lithium, and bromine brine project situated in Utah, United States. It owns a 100% interest in two battery mineral projects that is focused on copper/zinc development. Its pipeline products include SmoothX 2.0%, MultiX Thick, MultiX Thin, HDX, LDX, VY-101 and VY-103.

Managers	Title	Age	Since
Brent Willis FOU	Founder	-	17-12-05
Albert Deslauriers DFI	Director of Finance/CFO	-	22-08-16
Brad Willis COO	Chief Operating Officer	-	17-03-01

Members of the board	Title	Age	Since
Ronald L. Sifton BRD	Director/Board Member	71	20-01-19
Ralph Hesje BRD	Director/Board Member	-	21-07-25
Brent Willis FOU	Founder	-	17-12-05
Brad Willis COO	Chief Operating Officer	-	17-03-01
Eric Pommer BRD	Director/Board Member	-	-
Eugene Fritzel BRD	Director/Board Member	-	-

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	1	138,881,576	124,697,720 ( 89.79 %)	0	89.79 %

Name	Equities	%	Valuation
Brent Willis 5.203 %	6,904,167	5.203 %	276 167 $
Brad Willis 5.056 %	6,709,689	5.056 %	268 388 $
Ronald L. Sifton 0.4295 %	570,000	0.4295 %	22 800 $
Agustin Gago 0.000000 %	0	0.000000 %	- $
Ralph Hesje 0.000000 %	0	0.000000 %	- $
Albert Deslauriers 0.000000 %	0	0.000000 %	- $
Eric Pommer 0.000000 %	0	0.000000 %	- $
Leonard Fritzel Eugene 0.000000 %	0	0.000000 %	- $
Eugene Fritzel 0.000000 %	0	0.000000 %	- $
Kevin Richard Mcbeth 0.000000 %	0	0.000000 %	- $

Voyageur Pharmaceuticals Ltd.

Dome Tower 800 333 7 Avenue S W

T2P 2Z1, Calgary

http://www.voyageurminerals.ca

address Voyageur Pharmaceuticals Ltd.(VM)

Company calendar

Healthcare

Pharmaceuticals & Medical Research

Pharmaceuticals

Pharmaceuticals

Other Pharmaceuticals

	1st Jan change	Capi.
VOYAGEUR PHARMACEUTICALS LTD.	-26.67%	5.58M
ELI LILLY AND COMPANY	+31.06%	682B
NOVO NORDISK A/S	+30.35%	586B
JOHNSON & JOHNSON	-3.42%	364B
MERCK & CO., INC.	+18.02%	327B
ABBVIE INC.	+4.27%	285B
ASTRAZENECA PLC	+15.53%	240B
NOVARTIS AG	+10.16%	209B
ROCHE HOLDING AG	-8.14%	203B
AMGEN INC.	+8.12%	165B

Other Pharmaceuticals